These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2169331)

  • 1. WR-2721: a chemotherapy and radiation-protective agent.
    Schein PS
    Cancer Invest; 1990; 8(2):265-6. PubMed ID: 2169331
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the outlook grey for WR-2721 as a clinical radioprotector?
    Denekamp J; Stewart FA; Rojas A
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1247-9. PubMed ID: 6307942
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy.
    Glover D; Fox KR; Weiler C; Kligerman MM; Turrisi A; Glick JH
    Pharmacol Ther; 1988; 39(1-3):3-7. PubMed ID: 2849130
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitizers and protectors in clinical oncology.
    Phillips TL
    Semin Oncol; 1981 Mar; 8(1):65-82. PubMed ID: 6264627
    [No Abstract]   [Full Text] [Related]  

  • 5. Can WR-2721 be improved upon?
    Brown DQ; Graham WJ; MacKenzie LJ; Pittock JW; Shaw LM
    Pharmacol Ther; 1988; 39(1-3):157-68. PubMed ID: 2849121
    [No Abstract]   [Full Text] [Related]  

  • 6. [An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 2. Abdominal and pelvic tumors].
    Niibe H; Takahashi I; Miyaishi K; Mitsuhashi N; Maehara Y; Nakajima N; Suto H; Saito Y; Yamakawa M; Sugiyama S
    Nihon Gan Chiryo Gakkai Shi; 1985 Jun; 20(5):994-1001. PubMed ID: 2997352
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection of bone marrow by WR-2721 after fractionated irradiation.
    Coia LR; Brown DQ
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):908-9. PubMed ID: 2550401
    [No Abstract]   [Full Text] [Related]  

  • 8. Agent designed for war now in doctors' armamentarium.
    Mahaney FX
    J Natl Cancer Inst; 1990 Feb; 82(4):255-7. PubMed ID: 2153838
    [No Abstract]   [Full Text] [Related]  

  • 9. [An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 1. Head and neck tumors].
    Niibe H; Takahashi I; Mitsuhashi N; Miyaishi K; Itoh J; Maehara Y; Nakajima N; Suto H; Sakaino K; Matsuura S
    Nihon Gan Chiryo Gakkai Shi; 1985 Jun; 20(5):984-93. PubMed ID: 2997351
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I clinical trials of WR-2721 with alkylating agent chemotherapy.
    Glick JH; Glover DJ; Weiler C; Blumberg A; Nelson D; Yuhas JM; Kligerman M
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):575-80. PubMed ID: 6286556
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on radioprotectors in mammals and their possible use in radiotherapy--a summary.
    Kumar S
    Radiobiol Radiother (Berl); 1985; 26(3):359-65. PubMed ID: 2997830
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trials of WR-2721 with radiation therapy.
    Blumberg AL; Nelson DF; Gramkowski M; Glover D; Glick JH; Yuhas JM; Kligerman MM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):561-3. PubMed ID: 6286554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of WR 2721 on radiation response of canine soft tissue sarcomas.
    McChesney SL; Gillette EL; Dewhirst MW; Withrow SJ
    Int J Radiat Oncol Biol Phys; 1986 Nov; 12(11):1957-63. PubMed ID: 3021693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical use of radioprotector amifostine (YM-08310)].
    Takahashi I; Mitsuhashi N; Itoh J; Okazaki A; Ikeda H; Suto H; Yamakawa M; Nozaki M; Miyaishi K; Niibe H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Nov; 44(11):1396-404. PubMed ID: 6099539
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of WR-2721 in radiotherapy and/or chemotherapy.
    Yuhas JM; Spellman JM; Culo F
    Cancer Clin Trials; 1980; 3(3):211-6. PubMed ID: 6254681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amifostine as a supporting treatment during cancer therapy].
    Jantunen E; Puistola U
    Duodecim; 1999; 115(11):1223-7. PubMed ID: 11877841
    [No Abstract]   [Full Text] [Related]  

  • 17. Opposite effects of WR-2721 and WR-1065 on radiation-induced hypothermia: possible correlation with oxygen uptake.
    Kandasamy SB; Kumar KS; Hunt WA; Weiss JF
    Radiat Res; 1988 May; 114(2):240-7. PubMed ID: 2836882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of mouse lung by WR-2721 after fractionated doses of irradiation.
    Travis EL; De Luca AM
    Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):521-6. PubMed ID: 2982773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxicity and antiradiation activity of aminopropyl aminoethyl thiophosphate].
    Terekhov AV; Besedina LN; Zherebchenko PG; Znamenskiĭ VV; Suslikov VI; Titov BA
    Radiobiologiia; 1976; 16(2):249-52. PubMed ID: 189349
    [No Abstract]   [Full Text] [Related]  

  • 20. WR-2721 protects against the hematologic toxicity of cyclophosphamide.
    Phillips TL
    J Clin Oncol; 1986 Apr; 4(4):458. PubMed ID: 3007682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.